§ Mr. PageTo ask the Secretary of State for Health what assessment his Department has made of the effectiveness of(a) drug coated and (b) plain stents; and if he will publish relative success rates. [78580]
§ Ms Blears[holding answer 31 October 2002]: The Department referred drug coated stents, also called drug eluting stents, to the National Institute of Clinical Excellence (NICE) on 20 May this year for appraisal. NICE will produce technology appraisal guidance for the National Health Service on the clinical and cost effectiveness of drug eluting stents and on the appropriate use of this new technology. The Department does not currently collect information on the number of percutaneous coronary interventions that involve the use of stents or the relative success rates of different types of stent.
§ Mr. PageTo ask the Secretary of State for Health what guidelines his Department has issued to primary care trusts regarding the use of drug coated stents. [78581]
1996–97 1997–98 1998–99 1999–2000 2000–01 All completed injury and poisoning episodes 744,870 765,560 747,260 775,130 761,220 No external cause given 110,190 113,620 111,550 114,690 120,500 Percentage of total injury and poisoning 14.8 14.8 14.9 14.8 15.8 Note:
This information is taken from Hospital Episode Statistics system (HES) and relates to in-patients who have finished their hospital episodes under the care of a consultant and have been discharged, transferred to another hospital or consultant specialist or died.